Provided by Tiger Trade Technology Pte. Ltd.

Clearmind Medicine, Inc.

1.68
-0.0600-3.45%
Post-market: 1.720.0400+2.38%19:32 EDT
Volume:97.06K
Turnover:164.66K
Market Cap:2.50M
PE:-0.01
High:1.75
Open:1.75
Low:1.61
Close:1.74
52wk High:524.00
52wk Low:1.43
Shares:1.49M
Float Shares:1.48M
Volume Ratio:0.44
T/O Rate:6.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-175.9200
EPS(LYR):-303.4772
ROE:-114.61%
ROA:-51.35%
PB:0.22
PE(LYR):-0.01

Loading ...

SciSparc, Clearmind publish U.S. patent application for MDMA-PEA combination

TIPRANKS
·
Yesterday

Clearmind Medicine Says US Publishes MDMA-PEA Patent Application for PTSD Treatment

Reuters
·
Yesterday

Clearmind Advances Mdma-N-Acylethanolamines Ip for the Treatment of Ptsd Amid Rising U.S. Federal Support for Psychedelic Innovation

THOMSON REUTERS
·
Yesterday

Clearmind Advances CMND-100 into Alcohol Use Disorder Patients After Phase I/II Safety Milestone

Reuters
·
Aug 13

Clearmind Advances Cmnd-100 to Alcohol Use Disorder Patients After Achieving Primary Safety Endpoint

THOMSON REUTERS
·
Aug 13

Clearmind Medicine Announces Positive Permeation Results for Intranasal Meai Formulation

Reuters
·
Aug 11

Clearmind Medicine reports MEAI development program permeation study results

TIPRANKS
·
Aug 11

Clearmind Medicine Reports Positive Permeation Results for Intranasal MEAI Formulation Study

Reuters
·
Aug 11

Clearmind Medicine - Intranasal Meai Shows Enhanced Nasal Retention Without Compromising Permeation

THOMSON REUTERS
·
Aug 11

Clearmind Medicine reports DSMB approves advancing Phase I/II AUD study

TIPRANKS
·
Aug 06

Clearmind Advances CMND-100 Alcohol Use Disorder Trial into Patient Testing After Phase I Safety Readout

Reuters
·
Aug 06

Clearmind Reaches Key Clinical Trial Milestone as Dsmb Unanimously Clears Progression in AUD Study

THOMSON REUTERS
·
Aug 06

Clearmind Signs LOI to Buy 51% Stake in EV Wireless Charging Firm for $2.5 Million

Reuters
·
Aug 03

Clearmind Medicine Signs Letter of Intent to Acquire 51% Majority Stake in EV Wireless Charging Solutions for Automated Parking Systems Company

THOMSON REUTERS
·
Aug 03

Clearmind Medicine - to Extend $1.50 Mln Loan at 4% Interest, Repayable in Two Years

THOMSON REUTERS
·
Aug 03

Clearmind Medicine - Deal Valued at $2.50 Mln for 51% Majority Stake

THOMSON REUTERS
·
Aug 03

Psychedelic: Clearmind reports safety findings for CMND-100

TIPRANKS
·
Jul 30

Clearmind Medicine announces safety results from Part A of CMND-100 tral

TIPRANKS
·
Jul 30

Clearmind Reports Positive Safety, Tolerability in Cmnd-100 Phase I/II Trial Part a Dose Escalation

Reuters
·
Jul 30

Clearmind Medicine - Study Achieves Primary Endpoint of Safety and Tolerability for Cmnd-100

THOMSON REUTERS
·
Jul 30